PNC FINANCIAL SERVICES GROUP, INC. - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 27 filers reported holding EVOKE PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q3 2018$82,000
+18.8%
27,5000.0%0.00%
Q2 2018$69,000
+21.1%
27,5000.0%0.00%
Q1 2018$57,000
+103.6%
27,500
+120.0%
0.00%
Q4 2017$28,000
-53.3%
12,500
-30.6%
0.00%
Q3 2017$60,000
+30.4%
18,0000.0%0.00%
Q2 2017$46,000
-17.9%
18,0000.0%0.00%
Q1 2017$56,00018,0000.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 259,100$1,355,0000.54%
Knoll Capital Management, LLC 55,660$291,0000.09%
Financial Architects, Inc 2,150$11,0000.00%
Tower Research Capital LLC (TRC) 1,396$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 15,864$82,0000.00%
BlackRock Investment Management, LLC 489$3,0000.00%
DEUTSCHE BANK AG\ 1,062$5,0000.00%
MORGAN STANLEY 1,661$9,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$192,0000.00%
Renaissance Technologies 13,024$68,0000.00%
View complete list of EVOKE PHARMA INC shareholders